Results 51 to 60 of about 5,533 (163)

Eptifibatide and abciximab inhibit insulin-induced focal adhesion formation and proliferative responses in human aortic smooth muscle cells

open access: yesCardiovascular Diabetology, 2008
Background The use of abciximab (c7E3 Fab) or eptifibatide improves clinical outcomes in diabetics undergoing percutaneous coronary intervention. These β3 integrin inhibitors antagonize fibrinogen binding to αIIbβ3 integrins on platelets and ligand ...
Huang Jianhua   +3 more
doaj   +1 more source

Comparative efficacy of eptifibatide and abciximab in primary angioplasty study

open access: yesResearch Reports in Clinical Cardiology, 2011
Rohan Jayasinghe1 Matias Yudi1 Sanjay Jayasinghe21Cardiology Department, Gold Coast Hospital, Griffith University, Queensland, Australia; 2Centre for Immunisation Research, Sydney, AustraliaBackground: Primary percutaneous intervention is the safest and ...
Rohan Jayasinghe   +2 more
doaj  

Investigation of interaction of human platelet membrane components with anticoagulant drugs Abciximab and Eptifibatide

open access: yesFolia Histochemica et Cytobiologica, 2010
Abciximab (Abci) and eptifibatide (Epti) are antiaggregate drugs which may reduce thrombotic complications inacute coronary syndromes. The aim of this work was the investigation of the interaction between the phospholipid-GPIIb/IIIa glycoprotein complex ...
Ewa Gorodkiewicz   +2 more
doaj  

High bolus tirofiban vs abciximab in acute STEMI patients undergoing primary PCI - The tamip study

open access: yesHeart Views, 2012
Background: Primary percutaneous coronary intervention (PCI) has been shown to be an effective therapy for patients with acute myocardial infarction (MI). Glycoprotein (GP) IIb/IIIa receptor blockers reduce thrombotic complications in patients undergoing
Mohammed A Balghith
doaj   +1 more source

Gli antagonisti del recettore GPIIb/IIIa: farmacologia, clinica ed economia nelle sindromi coronariche acute NSTEMI e nelle rivascolarizzazioni per via percutanea

open access: yesFarmeconomia: Health Economics and Therapeutic Pathways, 2005
Inhibition of platelet glycoprotein IIb/IIIa (GP IIb/IIIa) receptor prevents platelet aggregation by controlling its final common pathway, the cross-binding of fibrinogen, bridging across adjacent platelets.
Lorenzo Pradelli
doaj   +1 more source

Intracranial bleeding mimicking an extensive acute myocardial infarction with reversible apical ballooning and systolic left ventricular dysfunction. A case report

open access: yesMonaldi Archives for Chest Disease, 2016
A novel syndrome with transient asynergy of the apical segments of the left ventricle, also known as tako-tsubo cardiomyopathy, has been recently described and presents characteristics and effects similar to acute myocardial infarction.
Antonio D’Aloia   +4 more
doaj   +1 more source

Terapia con anticuerpos monoclonales en Cardiología y Medicina Interna

open access: yesRevista Colombiana de Cardiología, 2016
La terapia biológica basada en anticuerpos monoclonales, constituyen una nueva herramienta terapéutica, que de la mano del desarrollo de la biología molecular permiten intervenir puntos claves en la etiopatogenia de la enfermedad, permitiendo una terapia
Christian David Adams-Sánchez   +1 more
doaj   +1 more source

Antiplatelet medications in acute coronary syndromes and percutaneous coronary interventions: focus on tirofiban

open access: yesКардиоваскулярная терапия и профилактика, 2008
The review presents literature data on the key role of platelet aggregation (PA) for intracoronary thrombogenesis in various acute coronary syndromes (ACS) and percutaneous coronary interventions (PCI).
T. A. Batyraliev   +4 more
doaj  

Immediate Spastic Hemiplegia following Coil Embolization of an Anterior Communicating Artery Aneurysm

open access: yesCase Reports in Neurology, 2011
Background: Acute ischemia typically results in a flaccid paralysis. An immediate spastic hemiparesis following ischemia has rarely been reported.
Jordan Dubow   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy